Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

133%

4 of 3 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05467007Not ApplicableCompleted

Urgent Care Management of Respiratory Illness Enabled With Novel Testing Pathway

Role: lead

NCT03809117Not ApplicableTerminated

Film Array Gastrointestinal Panel Compared to Usual Care for ED Evaluation of Infectious Diarrhea

Role: lead

NCT02914301Not ApplicableCompleted

Mobile App for Prenatal Care to Reduce Visits and Improve Satisfaction Study

Role: lead

NCT00382265Phase 4Completed

Tamsulosin for Urolithiasis in the Emergency Dept

Role: lead

All 4 trials loaded